1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Concept to Clinic: Commercializing Innovation (C3i) Program is sponsored by National Institute of Biomedical Imaging and Bioengineering (NIBIB), NIH. The C3i Program provides medical device innovators with specialized business frameworks and essential tools for successful translation of biomedical technologies from the lab to the market.
It fosters the development and commercialization of early-stage biomedical technologies by engaging investigators interested in understanding the market value of their innovation.
Get alerted about grants like this
Get emailed when new opportunities from “National Institute of Biomedical Imaging and Bioengineering (NIBIB), NIH” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Medical device innovators and investigators interested in commercializing early-stage biomedical technologies. Confirm the full requirements in the official notice before applying.
Concept to Clinic: Commercializing Innovation (C3i) Program is funded by National Institute of Biomedical Imaging and Bioengineering (NIBIB), NIH. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
NIBIB Trailblazer Award for New and Early Stage Investigators (R21) is a grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), NIH that funds high-risk, high-impact research at the intersection of engineering, physical sciences, and biomedical sciences. Eligible applicants are NIH-defined New or Early Stage Investigators who have not previously submitted R01 or R15 applications. Awards provide $400,000 in direct costs over three years. No preliminary data are required — projects should be exploratory, novel, and non-incremental. Applications are due June 16, 2026.
Funding Opportunity Announcement – NIBIB Technology Development Network Coordinating Centers (RFA‑EB‑26‑001) is sponsored by National Institute of Biomedical Imaging and Bioengineering (NIBIB), NIH. Funding Opportunity Announcement for NIBIB Technology Development Network Coordinating Centers is a grant from the National Institutes of Health (NIH) through the National Institute of Biomedical Imaging and Bioengineering (NIBIB) that will fund Coordinating Centers designed to …
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.
The April 14 SBIR/STTR reauthorization restarted NIH's small-business pipeline after the shutdown, but the real signal is the sequencing of the new Small Business 101 webinars: program overview June 9, budget July 14, foreign risk August 18.
Read articleNIH's accelerating use of multiyear-funded grants — 601 awards worth $402 million in the first half of FY26, against just 146 awards worth $75 million in the same window of FY24 — has produced a fiscal contraction at research universities that has begun cascading into PhD admissions. AAU member institutions are admitting smaller graduate cohorts than they did in 2024 or 2025, with downstream consequences for the biomedical workforce, lab continuity, and the foreign-student pipeline through 2030. Why the contraction is structural rather than cyclical, and what universities, PIs, and prospective trainees should be doing in the second half of 2026.
Read articleThe joint NSF-NIH Smart Health and Biomedical Research solicitation supports high-risk, high-reward AI/data science work in health — $300K per year for four years, with 20+ NIH institutes participating. Here is how the program actually selects winners.
Read article